Puma Biotechnology, Inc.PBYINASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-7.6%
5Y CAGR-9.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-7.6%/yr
vs -11.4%/yr prior
5Y CAGR
-9.7%/yr
Consistent
Acceleration
+3.8pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
7 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $71.02M | -11.4% |
| 2024 | $80.16M | -10.2% |
| 2023 | $89.31M | -0.7% |
| 2022 | $89.98M | -22.6% |
| 2021 | $116.29M | -1.9% |
| 2020 | $118.49M | -16.3% |
| 2019 | $141.64M | -3.1% |
| 2018 | $146.20M | +37.0% |
| 2017 | $106.70M | +98.3% |
| 2016 | $53.80M | - |